Prof. Antonino Musolino

Prof. Antonino Musolino is an Associate Professor of Medical Oncology at the University of Parma, Italy. He is also Head of the Breast Unit at the University Hospital of Parma. He achieved a PhD in Pathophysiology in 2009 at the University of Parma and a Master of Science in Epidemiology in 2017 at the University of Turin. His principal clinical and research interests are breast cancer, lymphomas, cancer epidemiology, and pharmacogenetics. Over the past 15 years, he has become increasingly involved in clinical trials, pharmacogenetics, and epidemiological studies focusing on individualized treatments for HER2-positive breast cancer. He is currently the Principal Investigator for several international multicenter breast cancer trials involving particularly targeted therapies. He publishes and lectures extensively. He was awarded the American Association for Cancer Research (AACR) Scholar-in-Training Award in recognition of promising cancer research at the 2007 AACR annual meeting. He is President of the Italian Oncology Group of Clinical Research (GOIRC) and a member of the Breast International Group (BIG) task force on early clinical research.